Clinical Trial Update: Transplantation of Human Embryonic Stem Cell-derived Progenitors in Severe Heart Failure [Phase 1]

View source ↗

Summary

This update notes the completion of a Phase 1 trial evaluating transplantation of human embryonic stem cell–derived progenitors for severe heart failure caused …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Ischemic Heart Disease

Drugs mentioned

• Human embryonic stem cell-derived progenitors

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Ischemic Heart Disease | Phase 1 | Status: COMPLETED